olivLaw · European equity research
Alkemy Capital Investments PLC ALK.L
United Kingdom · London Stock Exchange · ISIN GB00BMD6C023 · Vertical: Listed companies from United Kingdom
Alkemy Capital Investments PLC is a UK-listed holding company developing a lithium hydroxide processing facility in Teesside through its subsidiary Tees Valley Lithium Limited. The company is still in development with no operating revenue, and securing project financing, estimated at about 245 million USD, is the central open question.
At the close of 05 Nov 2026, Alkemy Capital Investments PLC (ALK.L) stock was 2.52 GBP (+0.00% on the day), with market capitalisation 24.8 m GBP, beta 0.61, 52-week range 2.08–4.45 GBP.
Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 46.5
- neutral
- Bollinger (20, 2)
- 2.17 – 2.86
- in the upper half of the band · %B 0.51 · band width 27.3%
- SMA 50 / 200
- 2.81 / 3.10
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.09 / -0.12
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | −11.4% | +0.4% | −11.8 pp | — |
| 3 months | −7.7% | −3.3% | −4.4 pp | — |
| 6 months | −25.8% | +4.0% | −29.7 pp | — |
| Year to date | −11.6% | +8.1% | −19.7 pp | — |
| 1 year | −13.8% | +10.7% | −24.5 pp | +6.7% |
| 3 years | +110.0% | +50.1% | +59.9 pp | +24.8% |
| 5 years | +73.8% | +43.6% | +30.2 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | unavailable | unavailable | unavailable |
| Revenue YoY | unavailable | unavailable | unavailable |
| Net income | -1.8 m | -1.4 m | -2.5 m |
| Net income YoY | unavailable | unavailable | unavailable |
| Diluted EPS | -0.23 | -0.16 | -0.25 |
| Diluted EPS YoY | unavailable | unavailable | unavailable |
| net % | unavailable | unavailable | unavailable |
| Free cash flow | unavailable | unavailable | unavailable |
Balance sheet & financial health
Fiscal year 2026 · 31 Jan 2026
- Cash
- 153.3 k GBP
- Financial debt
- 2.1 m GBP
- Net debt
- 1.9 m GBP
- Equity
- -707.4 k GBP
- Total assets
- 4.1 m GBP
- Debt / equity
- unavailable
- Current ratio
- 0.08x
- ROE
- unavailable
- ROA
- -107.6%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (GBP)
Income statement · GBP
| Line | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|
| Interest expense | 1.7 k | 135.1 k | 532.7 k | esef· 02 Sept 2026verified |
| Pre-tax income | -2.1 m | -1.4 m | -2.5 m | esef· 02 Sept 2026verified |
| Income tax | -325.0 k | 0 | 0 | esef· 02 Sept 2026verified |
| Net income | -1.8 m | -1.4 m | -2.5 m | esef· 02 Sept 2026verified |
| Diluted EPS | -0.23 | -0.16 | -0.25 | esef· 02 Sept 2026verified |
Balance sheet · GBP
| Line | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|
| Cash | 45.5 k | 16.7 k | 153.3 k | esef· 02 Sept 2026verified |
| Receivables | 126.3 k | 47.8 k | 141.3 k | esef· 02 Sept 2026verified |
| Current assets | 171.8 k | 64.5 k | 294.6 k | esef· 02 Sept 2026verified |
| Intangibles (excl. goodwill) | 317.1 k | 506.2 k | 3.8 m | esef· 02 Sept 2026verified |
| Total assets | 488.9 k | 570.7 k | 4.1 m | esef· 02 Sept 2026verified |
| Short-term debt | 102.3 k | 599.4 k | 904.9 k | esef· 02 Sept 2026verified |
| Long-term debt | — | 0 | 1.1 m | esef· 02 Sept 2026verified |
| Current liabilities | 1.0 m | 2.1 m | 3.6 m | esef· 02 Sept 2026verified |
| Total liabilities | — | 2.1 m | 4.8 m | esef· 02 Sept 2026verified |
| Equity | -520.6 k | -1.5 m | -707.4 k | esef· 02 Sept 2026verified |
| Shares outstanding at year end | 7.6 m | 8.8 m | 9.8 m | esef· 02 Sept 2026derived |
Cash flow · GBP
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 1 of at least 6
- score weight coverage: 4.2% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: 24.8 m GBP
Key indicators
Coverage and freshness
Score by group
4% · Insufficient data
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 1 of at least 6; score weight coverage: 4.2% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | unavailable | unavailable | — |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 0.1x | 0 (on a fixed band) | 100% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial0/100 · 1/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality· partialunavailable · 0/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
ALKEMY CAPITAL INVESTMENTS PLC (ALK.L). Latest full fiscal year: 2026; data up to 2026-01-31.
Financial indicators are unavailable.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (indicators available: 1 of at least 6; score weight coverage: 4.2% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
What contradicts it
- Current ratio: 0.1x
Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Listed companies from United Kingdom · same country · compared with 40 companies
Multiples and returns vs the median
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| BATS.LBritish American Tobacco P.L.C. | 104.3 bn | 13.5 | 16.5% | 30.3% | −1.0% | +7% / +88% |
| ABF.LAssociated British Foods PLC | 14.7 bn | 14.3 | 9.2% | 5.3% | −3.1% | −5% / −15% |
| 0EV1.LCarnival PLC | 5.5 bn | 4.1 | 46.7% | 13.4% | +6.4% | unavailable / unavailable |
| BAB.LBabcock International Group PLC | 5.1 bn | 24.7 | 34.7% | 4.1% | +7.2% | −10% / +158% |
| AUTO.LAutotrader Group PLC | 4.8 bn | 16.4 | 60.2% | 47.1% | +3.9% | −13% / −23% |
| BBY.LBalfour Beatty PLC | 4.2 bn | 16.3 | 23.2% | 2.8% | +15.2% | +20% / +160% |
| ABDN.LAberdeen Group PLC | 4.1 bn | 10.8 | 8.0% | 28.9% | −2.1% | +11% / +41% |
| BKG.LThe Berkeley Group Holdings PLC | 3.6 bn | 11.3 | 8.8% | 13.4% | −4.2% | −0% / −22% |
| BME.LB&M European Value Retail PLC | 2.9 bn | 17.4 | 21.2% | 2.8% | +3.7% | +68% / −51% |
| AJB.LAj Bell PLC | 2.4 bn | 22.8 | 49.9% | 33.1% | +18.0% | +8% / +128% |
| ASHM.LAshmore Group PLC | 1.4 bn | 13.9 | 13.1% | 71.6% | −0.1% | +28% / +18% |
| BCG.LBaltic Classifieds Group PLC | 1.2 bn | 23.2 | 15.8% | 57.6% | +6.9% | −99% / −99% |
| APN.LApplied Nutrition PLC | 763.6 m | 36.2 | 41.2% | 19.7% | +24.2% | +71% / unavailable |
| BAG.LA.G. Barr P.L.C. | 671.9 m | 14.4 | 14.4% | 10.8% | +4.0% | −7% / +26% |
| ASC.LAsos PLC | 494.5 m | — | -81.3% | -12.0% | −14.7% | +71% / +8% |
| ALFA.LAlfa Financial Software Holdings PLC | 486.8 m | 16.3 | 61.5% | 23.8% | +15.3% | −28% / +10% |
| AML.LAston Martin Lagonda Global Holdings PLC | 344.3 m | — | -93.4% | -39.2% | −20.6% | −45% / −85% |
| APTD.LAptitude Software Group PLC | 111.3 m | 28.5 | 7.2% | 6.2% | −7.3% | −30% / −23% |
| BMS.LBraemar PLC | 78.3 m | 39.2 | 2.7% | 1.7% | −4.4% | +13% / −11% |
| AMGO.LAmigo Holdings PLC | 9.9 m | — | — | — | −81.9% | +325% / +844% |
| ASBE.LAssociated British Engineering PLC | 605.3 k | — | -19.1% | — | unavailable | unavailable / unavailable |
| AMIF.LAmicorp Fs (uk) PLC | 221.6 k | 0.1 | 27.5% | 9.1% | +8.1% | unavailable / unavailable |
| AAF.LAirtel Africa PLC | — | — | 24.1% | 10.6% | +29.5% | −7% / +164% |
| AAL.LAnglo American PLC | — | — | -19.3% | -20.2% | +4.5% | +30% / +76% |
| ACG.LAcg Metals Limited | — | — | -80.3% | -32.0% | +134.8% | +60% / +63% |
1- and 3-year price returns: for ALK.L from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Alkemy Capital Investments PLC is a UK-listed holding company developing a lithium hydroxide processing facility in Teesside through its subsidiary Tees Valley Lithium Limited. The company is still in development with no operating revenue, and securing project financing, estimated at about 245 million USD, is the central open question 1.
SWOT
Strengths
- The company holds a project under development with significant capitalised costs and a clearly defined strategy centred on the Teesside facility 1.
- The holding structure allows resources to be concentrated on one main project through a dedicated operating subsidiary 1.
- Management states that informal discussions with potential financing providers are advanced, which suggests interest from capital markets 1.
Weaknesses
- The company has no operating revenue and continuing losses, funded through borrowings and share issues 1.
- Available capital is insufficient to complete the project, and the report flags a material uncertainty about going concern 1.
- Capitalisation of development costs involves significant management judgement, highlighted as a key audit matter 1.
Opportunities
- If the project proves economically viable, it could become a revenue source in a lithium hydroxide market that may grow.
- Securing financing on favourable terms could unlock the construction stage and could reduce the uncertainty about going concern.
- Identifying new acquisition opportunities could extend activity beyond the current project.
Threats
- A prolonged decline in the lithium hydroxide price could seriously affect financing capacity and future profitability 1.
- Failure to obtain financing could lead to insolvency of the company or group, as the report warns 1.
- Delays in obtaining permits or cost overruns could compromise the timetable and viability of the project 1.
Risks
- Economic viability of the projecthigh
Management has not yet determined whether the project is economically viable, and failure could result in the loss of costs already incurred 1.
- Funding requirementhigh
The company does not have the capital needed for construction and must raise additional financing within the next twelve months 1.
- Going concern uncertaintyhigh
The auditor reported a material uncertainty about going concern, directly linked to access to financing 1.
- Lithium hydroxide pricemedium
A significant price decline could negatively affect the ability to attract finance and generate profit 1.
- Permits and personnelmedium
Delays in obtaining licences or loss of qualified personnel could affect development of the project 1.
Investment thesis
What would need to be true (bull case)
- If financing is secured and the project proves viable, the company could turn capitalised development costs into a productive facility with its own revenue 1.
- The lithium hydroxide market could offer favourable conditions, and the Teesside location could bring strategic advantages 1.
- Management states that discussions with potential financing providers are advanced, which could accelerate unlocking the project 1.
What would break the thesis
- The company has no revenue, recurring losses and insufficient capital, which could lead to dilution or insolvency 1.
- The auditor flagged a material uncertainty about going concern, and capitalising costs depends on subjective judgements 1.
- Economic viability of the project is not yet confirmed, and if the lithium price falls, financing could become unavailable 1.
What to watch
- Securing financing for the Teesside projectnext 12 months
- Decision on the economic viability of the project2027
- Evolution of the lithium hydroxide price2027
- Next annual report and going concern disclosuresnext annual report
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Alkemy Capital Investments PLC acts as the holding company for Tees Valley Lithium Limited, the operating subsidiary preparing to build a lithium hydroxide processing facility in Teesside, UK 1. According to its stated strategy, the company aims to generate value for shareholders through creating this project, which is currently its principal activity 1. At 31 January 2026, total assets were 4.05 million GBP, mostly consisting of capitalised project development costs 1.
Risks identified by management include the possibility that the project is not economically viable, the need for additional capital within the next twelve months, and the dependence of lithium hydroxide prices on external factors 1. If financing cannot be secured on acceptable terms, development of the project could be significantly affected 1.
Segments
Market context
The project targets the lithium hydroxide market, whose price is influenced by industrial demand, production levels, speculative activity and global or regional political and economic events 1. The company has noted that a significant and prolonged price decline could affect its ability to attract finance and generate profit 1. The specific market outlook is not detailed in the source.
Project financing depends on the availability of debt and equity capital, and management states that informal discussions with potential providers are ongoing 1. Market conditions for such financing are not described in the report.
Trends
- Project funding requirementmixed
If financing of approximately 245 million USD is obtained on acceptable terms, development could advance; otherwise continued activity could be compromised 1.
- Lithium hydroxide pricemixed
The price of lithium hydroxide, driven by external factors, may influence future revenues and financing capacity 1.
- Construction and procurement costsheadwind
Construction of industrial facilities is capital intensive, and shortages of equipment and delivery delays could increase costs 1.
- Permits and licencesheadwind
Obtaining or renewing authorisations needed for operations may delay project development 1.
Competitive position
The analysed source does not identify direct competitors and does not compare the company's position with other lithium hydroxide producers 1. The company describes its strategy as focused on its own project, without a competitor analysis.
Management notes that success depends on identifying suitable acquisition opportunities and attracting qualified personnel 1. Failure in these areas could affect the company's competitive position.
- Lithium hydroxide producers
The source does not name competitors; this category refers to companies in the lithium industry selling hydroxide in the market.
- Mineral project developers
Competitors for financing and qualified personnel, as noted in the risks described in the report.
- Investors in lithium projects
Parties that could provide the required financing but also compete for the same capital opportunities.
- Processing equipment suppliers
Suppliers in a contested market that can influence construction timelines and costs.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202602 Sept 2026
- Annual report 202502 Sept 2026
Sources
- [1] Annual report, fiscal year ended 2026-01-31 (ESEF) · SEC / Alkemy Capital Investments PLC · 31 Jan 2026
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.